Metabolic Hyperpigmentation: Carotenemia, Pernicious Anemia, Acromegaly, Addison’s Disease, Diabetes mellitus, and Hemochromatosis

Chapter
First Online:

Abstract

Acquired diffuse hyperpigmentation in children secondary to metabolic disorders can be divided into nutritional diseases, endocrinological disorders, and metabolic causes. Although pigmentation is categorized as diffuse, it is often accentuated in some areas. Adequate approach of diffuse hyperpigmentation may lead to the early diagnosis of a specific disease. The initial and most prominent sign can be in the skin and thus the dermatologist is the first physician consulted.

Keywords

Pediatric Diffuse hyperpigmentation Metabolic hyperpigmentation 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Hess AF, Meyers VC. Carotenemia. A new clinical picture. JAMA. 1919;73:1743–5.CrossRefGoogle Scholar
  2. 2.
    Venkatesh KS, Campbell-Davidson D, Isherwood D. Carotenemia in infancy and its association with prevalent feeding practices. Pediatr Dermatol. 2006;23:571–3.CrossRefGoogle Scholar
  3. 3.
    Congdon PJ, Kelleher J, Edwards P, Littlewood JM. Benign carotenaemia in children. Arch Dis Child. 1981;56:292–4.CrossRefPubMedCentralPubMedGoogle Scholar
  4. 4.
    Lascari AD. Carotenemia: a review. Clin Pediatr. 1981;20:25–9.CrossRefGoogle Scholar
  5. 5.
    Svensson A, Vahlquist A. Metabolic carotenemia and carotenoderma in a child. Acta Derm Venereol. 1995;75:70–1.PubMedGoogle Scholar
  6. 6.
    Loukili NH, Noel E, Blaison G, Goichot B, Kaltenbach G, Rondeau M, Andrès E. Update of pernicious anemia. A retrospective study of 49 cases. Rev Med Interne. 2004;25:556–61.CrossRefPubMedGoogle Scholar
  7. 7.
    Baker SJ, Ignatius M, Johnson S, Vaish SK. Pigmentation and vitamin B12 deficiency. Br Med J. 1963;2:1205.CrossRefPubMedCentralPubMedGoogle Scholar
  8. 8.
    Cherqaoui R, Husain M, Madduri S, Okolie P, Nunlee-Bland G, Williams J. A reversible cause of skin hyperpigmentation and postural hypotension. Case Rep Hematol. 2013;2013:680459.PubMedCentralPubMedGoogle Scholar
  9. 9.
    Kannan R. Cutaneous lesions and vitamin B12 deficiency. An often-forgotten link. Can Fam Physician. 2008;54:529–32.PubMedCentralPubMedGoogle Scholar
  10. 10.
    Aaron S, Kumar S, Vijayan J, Jacob J, Alexander M, Gnanamuthu C. Clinical and laboratory features and response to treatment in patients presenting with vitamin B12 deficiency-related neurological syndromes. Neurol India. 2005;53:55–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Feingold KR, Elias PM. Endocrine-skin interactions. Cutaneous manifestations of pituitary disease, thyroid disease, calcium disorders, and diabetes. J Am Acad Dermatol. 1987;17:921–40.CrossRefPubMedGoogle Scholar
  12. 12.
    Jabbour SA. Cutaneous manifestations of endocrine disorders: a guide for dermatologists. Am J Clin Dermatol. 2003;4:315–31.CrossRefPubMedGoogle Scholar
  13. 13.
    De Majo SF, Onativia A. Acromegaly and gigantism in a boy: comparison with three overgrown non-acromegalic children. J Pediatr. 1960;57:382–90.CrossRefGoogle Scholar
  14. 14.
    Spence HJ, Trias EP, Raiti S. Acromegaly in a nine and a half year old boy. Pituitary function studies before and after surgery. Am J Dis Child. 1972;123:504–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Laureti S, Vecchi L, Santeusanio F, Falorni A. Is the prevalence of Addison’s disease under estimated? J Clin Endocrinol Metab. 1999;84:1762.PubMedGoogle Scholar
  16. 16.
    Norup J. Addison’s disease-clinical studies. A report of 108 cases. Acta Endocrinol. 1974;76:127.Google Scholar
  17. 17.
    Simm PJ, McDonnell CM, Zacharin MR. Primary adrenal insufficiency in childhood and adolescence: advances in diagnosis and management. J Paediatr Child Health. 2004;40:596–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Grant DB, Barnes ND, Moncrieff MW, Savage MO. Clinical presentation, growth and pubertal development in Addison’s disease. Arch Dis Child. 1985;60:925–8.CrossRefPubMedCentralPubMedGoogle Scholar
  19. 19.
    Shulman DI, Palmert MR, Kemp SF. Adrenal insufficiency: still a cause of morbidity and death in childhood. Pediatrics. 2007;119:e484–94.CrossRefPubMedGoogle Scholar
  20. 20.
    Kong AS, Vanderbloemen L, Skipper B, Leggott J, Sebesta E, Glew R, Burge MR. Acanthosis nigricans predicts the clustering of metabolic syndrome components in Hispanic elementary school-aged children. J Pediatr Endocrinol Metab. 2012;25:1095–102.PubMedCentralPubMedGoogle Scholar
  21. 21.
    Stuart CA, Pate CJ, Peters EJ. Prevalence of acanthosis nigricans in an unselected population. Am J Med. 1989;87:269–72.CrossRefPubMedGoogle Scholar
  22. 22.
    Longo N, Wang Y, Smith SA, Langley SD, DiMeglio LA, Giannelle-Neto D. Genotype-phenotype correlation in inherited severe insulin resistance. Hum Mol Genet. 2002;11:1465–75.CrossRefPubMedGoogle Scholar
  23. 23.
    Sinha S, Schwartz RA. Juvenile Acanthosis nigricans. J Am Acad Dermatol. 2007;57:502–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol. 1994;31:1.CrossRefPubMedGoogle Scholar
  25. 25.
    Crownover BK, Covey CJ. Hereditary hemochromatosis. Am Fam Physician. 2013;87:183–90.PubMedGoogle Scholar
  26. 26.
    Barton JC, Rao SU, Pereira NM, Gelbart T, Beutler E, Rivers CA, Acton RT. Juvenile hemochromatosis in the southeastern United States: a report of seven cases in two kinships. Blood Cells Mol Dis. 2002;29:104–15.CrossRefPubMedGoogle Scholar
  27. 27.
    Cheurant-Breton J, Simon M, Bourel M, Ferrand B. Cutaneous manifestations of idiopathic hemochromatosis. Arch Dermatol. 1977;113:161.CrossRefGoogle Scholar
  28. 28.
    Moretti D, van Doorn GM, Swinkels DW, Melse-Boonstra A. Relevance of dietary iron intake and bioavailability in the management of HFE hemochromatosis: a systematic review. Am J Clin Nutr. 2013;98:468–79.CrossRefPubMedGoogle Scholar
  29. 29.
    Perdrup A, Poulsen H. Hemochromatosis and vitiligo. Arch Dermatol. 1964;90:34.CrossRefPubMedGoogle Scholar
  30. 30.
    Nadakkavukaran IM, Gan EK, Olynyk JK. Screening for hereditary hemochromatosis. Pathology. 2012;44:148–52.CrossRefPubMedGoogle Scholar
  31. 31.
    Szalay F. Hemochromatosis: one form of iron-overload diseases. Orv Hetil. 2013;154:1156–64.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Luz Orozco-Covarrubias
    • 1
  • Marimar Sáez-de-Ocariz
    • 1
  1. 1.Department of DermatologyNational Institute of Pediatrics, Insurgentes Sur 3700-C, Col. Insurgentes-CuicuilcoCoyoacánMexico

Personalised recommendations